🔎 Trials Near Me

Početna › Melanom › Iowa

Kliničke studije za Melanom u državi Iowa

12 studija za Melanom traži sudionike na lokacijama u državi Iowa.

Gradovi u državi Iowa

Službeni tekst studije (engleski)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • i još 12
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • i još 10
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • McFarland Clinic - Boone, Boone
  • i još 10
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013

Project: Every Child for Younger Patients With Cancer

  • Blank Children's Hospital, Des Moines
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • University of Iowa, Iowa City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT04895709

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

  • University of Iowa, Iowa City
U tijeku regrutacijaFaza 1/2
Od 18 do 90 godina · Oba spola · Ažurirano 10. lip 2026. · NCT05655312

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • University of Iowa, Iowa City
U tijeku regrutacijaFaza 2/3
Sve dobne skupine · Oba spola · Ažurirano 2. tra 2026. · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • i još 10
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. ožu 2026. · NCT06418204

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

  • University of Iowa, Iowa City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 13. velj 2026. · NCT04903119

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

  • University of Iowa, Iowa City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 3. pro 2025. · NCT06194929

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Iowa City
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.